Subscribe
Subscribe to C2Bio
Once a week, C2Bio publishes a single curated digest covering the most important developments in AI/ML and biotech. One email, every week — free.
Each weekly digest includes
- AI/ML research — notable preprints and methods from arXiv and top journals
- Biotech news — clinical trial readouts, drug approvals, and industry developments
- FDA catalyst brief — upcoming PDUFA dates and regulatory decisions for the week ahead
No spam. Unsubscribe any time. Full archive at c2bio.substack.com.
Comments
Post a Comment